ch.oddb.org
 
Apotheken | Hôpital | Interactions | LiMA | Médecin | Médicaments | Services | T. de l'Autorisation
Information professionnelle sur Metoflex® 750 mg:Labatec Pharma SA
Information professionnelle complèteDDDAfficher les changementsimprimé 
Composit.Forme gal.Indic./emploiPosolog./mode d'empl.Contre-Ind.PrécautionsInteract.Grossesse
Apt.conduiteEffets indésir.SurdosagePropriétésPharm.cinét.Donn.précl.RemarquesNum. Swissmedic
PrésentationsTitulaireMise à jour 
M03BA03 - MethocarbamolATC-DDD Version 2016. Source: WHO
M - Musculo-Skeletal System
 
M03 - Muscle Relaxants

This group comprises peripherally, centrally and directly acting muscle relaxants.
See also G04BD - Drugs for urinary frequency and incontinence.

M03B - Muscle Relaxants, Centrally Acting Agents

This group comprises centrally acting muscle relaxants. Combined preparations are classified at separate 5th levels using the corresponding 50-series (comb. excl. psycholeptics), or the 70-series (comb. with psycholeptics):
The group is subdivided according to chemical structure.
Combinations with NSAIDs (M01A), analgesics (N02B) or corticosteroids (H02A) are classified here.

These drugs are used in different conditions associated with pain and rigidity in the muscles, joints etc.
DDDs for combination products, see list on the website atcddd.fhi.no.

M03BA - Carbamic Acid Esters
 
M03BA03 - Methocarbamol
Concentr.Adm.RouteNote
 P 
 O 
2025 ©ywesee GmbH
Einstellungen | Aide | FAQ | Identification | Contact | Home